Cubic Asset Management’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $4K | Hold |
10,000
| – | – | ﹤0.01% | 200 |
|
|
2023
Q4 | $5.9K | Hold |
10,000
| – | – | ﹤0.01% | 202 |
|
|
2023
Q3 | $5.25K | Hold |
10,000
| – | – | ﹤0.01% | 199 |
|
|
2023
Q2 | $1.9K | Hold |
10,000
| – | – | ﹤0.01% | 199 |
|
|
2023
Q1 | $3.4K | Sell |
10,000
-4,000
| -29% | -$1.36K | ﹤0.01% | 194 |
|
|
2022
Q4 | $4.53K | Hold |
14,000
| – | – | ﹤0.01% | 194 |
|
|
2022
Q3 | $6K | Hold |
14,000
| – | – | ﹤0.01% | 192 |
|
|
2022
Q2 | $6K | Hold |
14,000
| – | – | ﹤0.01% | 193 |
|
|
2022
Q1 | $18K | Hold |
14,000
| – | – | ﹤0.01% | 195 |
|
|
2021
Q4 | $18K | Buy |
14,000
+900
| +7% | +$1.16K | ﹤0.01% | 203 |
|
|
2021
Q3 | $27K | Buy |
13,100
+250
| +2% | +$515 | 0.01% | 186 |
|
|
2021
Q2 | $20K | Buy |
12,850
+1,350
| +12% | +$2.1K | ﹤0.01% | 184 |
|
|
2021
Q1 | $26K | Buy |
11,500
+250
| +2% | +$565 | 0.01% | 178 |
|
|
2020
Q4 | $28K | Buy |
11,250
+750
| +7% | +$1.87K | 0.01% | 168 |
|
|
2020
Q3 | $26K | Buy |
+10,500
| New | +$26K | 0.01% | 155 |
|